Correlation of plasma and neuroimaging biomarkers in Alzheimer’s disease
dc.contributor.author | Brickman, Adam M. | |
dc.contributor.author | Manly, Jennifer J. | |
dc.contributor.author | Honig, Lawrence S. | |
dc.contributor.author | Sanchez, Danurys | |
dc.contributor.author | Reyes-Dumeyer, Dolly | |
dc.contributor.author | Lantigua, Rafael A. | |
dc.contributor.author | Vonsattel, Jean Paul | |
dc.contributor.author | Teich, Andrew F. | |
dc.contributor.author | Kang, Min Suk | |
dc.contributor.author | Dage, Jeffrey L. | |
dc.contributor.author | Mayeux, Richard | |
dc.contributor.department | Neurology, School of Medicine | en_US |
dc.date.accessioned | 2023-06-22T11:55:09Z | |
dc.date.available | 2023-06-22T11:55:09Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Blood-based phosphorylated tau (Ptau) 181 and 217 biomarkers are sensitive and specific for Alzheimer's disease. In this racial/ethnically diverse cohort study, participants were classified as biomarker positive (Ptau+) or negative (Ptau-) based on Ptau 181 and 217 concentrations and as cognitively impaired (Sym) or unimpaired (Asym). The four groups, Ptau-/Asym, Ptau+/Asym, Ptau-/Sym, and Ptau+/Sym, differed by age, APOE-4 allele frequency, total tau, neurofilament light chain, and cortical thickness measured by MRI. Our results add to increasing evidence that plasma Ptau 181 and 217 concentrations are valid Alzheimer's disease biomarkers in diverse populations. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Brickman AM, Manly JJ, Honig LS, et al. Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease. Ann Clin Transl Neurol. 2022;9(5):756-761. doi:10.1002/acn3.51529 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/33928 | |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/acn3.51529 | en_US |
dc.relation.journal | Annals of Clinical and Translational Neurology | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | Alzheimer disease | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Magnetic resonance imaging | en_US |
dc.subject | Neuroimaging | en_US |
dc.title | Correlation of plasma and neuroimaging biomarkers in Alzheimer’s disease | en_US |
dc.type | Article | en_US |